CN Patent

CN111269233A — 一类咪唑并芳环类化合物的制备和应用

Assigned to Shanghai Ennovabio Pharmaceuticals Co Ltd · Expires 2020-06-12 · 6y expired

What this patent protects

本发明提供了一类芳香酰胺化合物的制备和应用，具体地，本发明提供了一种如下式I所示的化合物，其中，各基团的定义如说明书中所述。所述的化合物具有TRK激酶抑制活性，可以作为治疗TRK功能异常相关疾病的药物组合物。

USPTO Abstract

本发明提供了一类芳香酰胺化合物的制备和应用，具体地，本发明提供了一种如下式I所示的化合物，其中，各基团的定义如说明书中所述。所述的化合物具有TRK激酶抑制活性，可以作为治疗TRK功能异常相关疾病的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN111269233A
Jurisdiction
CN
Classification
—
Expires
2020-06-12
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Ennovabio Pharmaceuticals Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.